Regulation of fetal hemoglobin synthesis by cell cycle specific drugs.
Nathan
D G
DG
D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy; D000818:Animals; D002453:Cell Cycle / Q000187:drug effects*; D003114:Colony-Forming Units Assay; D004247:DNA / Q000032:analysis; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000378:metabolism; D004262:DNA Restriction Enzymes / Q000378:metabolism; D004334:Drug Administration Schedule; D004920:Erythropoiesis; D005260:Female; D005319:Fetal Hemoglobin / Q000096:biosynthesis*; D005786:Gene Expression Regulation; D005914:Globins / Q000235:genetics; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006441:Hemoglobin A / Q000032:analysis; D006453:Hemoglobinopathies / Q000235:genetics; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007700:Kinetics; D008252:Macaca fascicularis; D012156:Reticulocytes / Q000187:drug effects; D014747:Vinblastine / Q000627:therapeutic use
D014747:Vinblastine; D005914:Globins; D004247:DNA; D006441:Hemoglobin A; D005319:Fetal Hemoglobin; D004248:DNA (Cytosine-5-)-Methyltransferases; D004262:DNA Restriction Enzymes; D006918:Hydroxyurea